ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 861 filers reported holding ISHARES TR in Q4 2020. The put-call ratio across all filers is 1.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $871,684 | -3.4% | 7,128 | +0.3% | 0.18% | +0.6% |
| Q2 2023 | $902,051 | -1.5% | 7,105 | +0.2% | 0.18% | -4.8% |
| Q1 2023 | $915,874 | -1.6% | 7,091 | -0.0% | 0.19% | -5.6% |
| Q4 2022 | $931,109 | +13.1% | 7,092 | +0.8% | 0.20% | +11.2% |
| Q3 2022 | $823,000 | +2.7% | 7,038 | +3.3% | 0.18% | +8.5% |
| Q2 2022 | $801,000 | -9.4% | 6,811 | +0.4% | 0.16% | +2.5% |
| Q1 2022 | $884,000 | -11.9% | 6,785 | +3.3% | 0.16% | -9.1% |
| Q4 2021 | $1,003,000 | -6.6% | 6,570 | -1.1% | 0.18% | -10.2% |
| Q3 2021 | $1,074,000 | -1.8% | 6,642 | -0.6% | 0.20% | -1.5% |
| Q2 2021 | $1,094,000 | -3.9% | 6,685 | -11.6% | 0.20% | -7.4% |
| Q1 2021 | $1,138,000 | -13.3% | 7,559 | -12.7% | 0.22% | -20.1% |
| Q4 2020 | $1,312,000 | +6.4% | 8,661 | -4.9% | 0.27% | +2.7% |
| Q3 2020 | $1,233,000 | -5.2% | 9,106 | -4.3% | 0.26% | -8.4% |
| Q2 2020 | $1,300,000 | +23.3% | 9,512 | -2.8% | 0.29% | +4.0% |
| Q1 2020 | $1,054,000 | -12.5% | 9,787 | -2.1% | 0.28% | +0.7% |
| Q4 2019 | $1,205,000 | +26.3% | 9,998 | +4.3% | 0.27% | +18.2% |
| Q3 2019 | $954,000 | -9.3% | 9,588 | -0.5% | 0.23% | -11.2% |
| Q2 2019 | $1,052,000 | -2.4% | 9,640 | 0.0% | 0.26% | -4.4% |
| Q1 2019 | $1,078,000 | +17.0% | 9,640 | +0.9% | 0.27% | +6.7% |
| Q4 2018 | $921,000 | -21.9% | 9,551 | -1.2% | 0.26% | -13.9% |
| Q3 2018 | $1,179,000 | +4.9% | 9,669 | -5.5% | 0.30% | -38.6% |
| Q2 2018 | $1,124,000 | -6.2% | 10,235 | -8.8% | 0.48% | -6.2% |
| Q1 2018 | $1,198,000 | -4.8% | 11,222 | -4.8% | 0.51% | -1.5% |
| Q4 2017 | $1,259,000 | -5.0% | 11,791 | +196.8% | 0.52% | -10.2% |
| Q3 2017 | $1,325,000 | +2.1% | 3,973 | -5.1% | 0.58% | +0.2% |
| Q2 2017 | $1,298,000 | -2.5% | 4,185 | -7.8% | 0.58% | -7.1% |
| Q1 2017 | $1,331,000 | +8.3% | 4,538 | -2.0% | 0.62% | +0.8% |
| Q4 2016 | $1,229,000 | -7.8% | 4,630 | +0.6% | 0.62% | -10.3% |
| Q3 2016 | $1,333,000 | +15.9% | 4,604 | +3.0% | 0.69% | +8.8% |
| Q2 2016 | $1,150,000 | -2.5% | 4,469 | -1.1% | 0.63% | -5.9% |
| Q1 2016 | $1,179,000 | – | 4,520 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |